Trials / Completed
CompletedNCT04580953
A Prospective Clinical Study Aimed to Assess the Technical Feasibility of RR2 Wearable Home Care Neuromodulation System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Ziv HealthCare Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RR2 is a medical, home-care, digital therapeutic, wearable device. Its main purpose is to deliver prescheduled, non-invasive, peripheral neuromodulation therapy, in conjunction with standard medical care, to relieve AF symptoms, recurrence and overall burden.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CardiaCareTM RR2 | Treatment with CardiaCareTM RR2 |
Timeline
- Start date
- 2021-01-28
- Primary completion
- 2022-01-02
- Completion
- 2022-01-02
- First posted
- 2020-10-09
- Last updated
- 2022-02-22
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04580953. Inclusion in this directory is not an endorsement.